RVL Pharmaceuticals Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 1/6
RVL Pharmaceuticals has a total shareholder equity of $16.3M and total debt of $57.7M, which brings its debt-to-equity ratio to 353.7%. Its total assets and total liabilities are $85.4M and $69.1M respectively.
Wichtige Informationen
353.7%
Verhältnis von Schulden zu Eigenkapital
US$57.75m
Verschuldung
| Zinsdeckungsgrad | n/a |
| Bargeld | US$19.16m |
| Eigenkapital | US$16.33m |
| Gesamtverbindlichkeiten | US$69.08m |
| Gesamtvermögen | US$85.40m |
Jüngste Berichte zur Finanzlage
RVL Pharmaceuticals (NASDAQ:RVLP) Is Making Moderate Use Of Debt
Apr 20
Is RVL Pharmaceuticals (NASDAQ:RVLP) Using Debt Sensibly?
Jan 05RVL Pharmaceuticals (NASDAQ:RVLP) Is Carrying A Fair Bit Of Debt
Jul 04Recent updates
RVL Pharmaceuticals plc (NASDAQ:RVLP) Analysts Just Cut Their EPS Forecasts Substantially
Aug 16Analysts Just Made A Major Revision To Their RVL Pharmaceuticals plc (NASDAQ:RVLP) Revenue Forecasts
May 13RVL Pharmaceuticals plc (NASDAQ:RVLP) Doing What It Can To Lift Shares
May 12RVL Pharmaceuticals (NASDAQ:RVLP) Is Making Moderate Use Of Debt
Apr 20Is RVL Pharmaceuticals (NASDAQ:RVLP) Using Debt Sensibly?
Jan 05RVL Pharmaceuticals sees Q3 net sales of UPNEEQ for eye treatment about $10M
Oct 18RVL Pharmaceuticals: Chapter 2 - A Developing Quandary
Sep 22RVL Pharma in pact with Revision Skincare to broaden access to products
Aug 30GAAP EPS of -$0.14 beats by $0.07, revenue of $8.45M misses by $0.07M
Aug 11RVL Pharma posts preliminary 42% sales growth for eye treatment
Jul 07RVL Pharmaceuticals (NASDAQ:RVLP) Is Carrying A Fair Bit Of Debt
Jul 04RVL Pharmaceuticals: Chapter 1 Gives A Mixed Picture
Jun 15New Forecasts: Here's What Analysts Think The Future Holds For RVL Pharmaceuticals plc (NASDAQ:RVLP)
Apr 01RVL Pharmaceuticals: A Makeover For An Ugly Duckling
Mar 30Osmotica: A Different Breed Of Cat
Dec 14Osmotica Pharmaceuticals (NASDAQ:OSMT) Takes On Some Risk With Its Use Of Debt
Aug 20Osmotica: Paring Down, Focusing On UPNEEQ
Jul 16Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: RVLP.Q's short term assets ($25.8M) do not cover its short term liabilities ($68.4M).
Langfristige Verbindlichkeiten: RVLP.Q's short term assets ($25.8M) exceed its long term liabilities ($686.0K).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: RVLP.Q's net debt to equity ratio (236.4%) is considered high.
Schulden abbauen: RVLP.Q's debt to equity ratio has increased from 75.8% to 353.7% over the past 5 years.
Bilanz
Liquiditätsreserve-Analyse
Bei Unternehmen, die in der Vergangenheit im Durchschnitt Verluste gemacht haben, wird geprüft, ob sie über einen Liquiditätsvorlauf von mindestens einem Jahr verfügen.
Stabile Start- und Landebahn für Bargeld: Insufficient data to determine if RVLP.Q has enough cash runway based on its current free cash flow.
Vorhersage Cash Runway: Insufficient data to determine if RVLP.Q has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.